Naprosyn 10% Naproxen Gel 50g

NAME
NAPROSYN 10% GEL

PHARMACOTHERAPEUTIC CATEGORY
Topical medications for joint and muscle pain.

ACTIVE PRINCIPLES
Naproxen.

EXCIPIENTS
Carbomer, ethanol, triethanolamine, sodium metabisulfite, rose scent, purified water.

INDICATIONS
Myalgia, lumbago, stiff neck, fibromyositis, bursitis, tendinitis, tenosynovitis, periarthritis, bruises, muscle tears, sprains, hematomas, edema and traumatic infiltrates, phlebitis; adjuvant of orthopedic and rehabilitation therapies.

CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity to the active ingredient or to closely related substances from a chemical point of view and / or to any of the listed excipients; the risk of harmful effects on the fetus and / or the child is not excluded; therefore the use of the drug during pregnancy and / or breastfeeding is to be reserved for cases of absolute necessity.

DOSAGE
Spread the gel on the pain site, 2 times a day, massaging lightly until completely absorbed.

STORAGE
This medicine does not require any special storage conditions.

WARNINGS
Avoid using the gel on wounds. The product contains sodium metabisulfite. The quantity of active principle absorbed through the skin does not reach such concentrations in circulation as to expose to the risks of side effects and to make valid the warnings relating to the administration of the drug systemically. However, the use of the medicine is not recommended for patients in whom acetylsalicylic acid and / or other NSAIDs induce allergic reactions and it is also not recommended for patients with active allergic manifestations or medical history. a large area and for a prolonged period of time, the appearance of systemic side effects cannot be excluded. To avoid any phenomena of hypersensitivity or photosensitization avoid exposure to direct sunlight, including the solarium, during the treatment and in the following two weeks.

INTERACTIONS
Possible synergism with systemic anti-inflammatory therapies.

SIDE EFFECTS
With some non-steroidal anti-inflammatory drugs for topical cutaneous or transdermal use, derivatives of propionic acid, adverse skin reactions with erythema, itching, irritation, sensation of heat or burning and contact dermatitis have been reported. Some cases of bullous eruptions of varying severity have also been reported. Photosensitivity reactions are possible. The use, especially if prolonged of the products for topical use, can give rise to sensitization phenomena. In this case, suspend the treatment and adopt suitable therapeutic measures. The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug.

PREGNANCY AND BREASTFEEDING
The risk of harmful effects on the fetus and / or the child is not excluded. Therefore, the use of the drug during pregnancy and / or breastfeeding is to be reserved for cases of absolute necessity.